In Emergency Motion, Novartis and BMS Urge Appellate Court to Fast-Track Their Appeals of 340B Rebate Ruling

Novartis and BMS filed an emergency motion with the federal appeals court in Washington, D.C. to appeal a recent ruling on drugmaker 340B rebates.
Novartis and Bristol Myers Squibb (BMS) are asking a federal appeals court to expedite their challenge to a recent ruling [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Premier Asks Court to Reject HRSA’s Defense of 340B Hospital Drug Purchasing Restrictions Policy, Requests Oral Arguments

Premier again asked a Washington D.C. federal court to strike down a HRSA policy that restricts how certain 340B hospitals can purchase initial drug inventory.
A major group purchasing organization (GPO) recently urged a Washington D.C. federal court to reject the federal government’s defense of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: Drugmakers File Briefs in 5th Circuit Appeals Case, Updates in Utah and Nebraska

Key briefs were filed in litigation on contract pharmacy access laws in Louisiana, Utah and Nebraska.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AbbVie Sues Hawaii Over New 340B Contract Pharmacy Access Law

AbbVie filed a June 2 lawsuit challenging the constitutionality of Hawaii's newly enacted 340B contract pharmacy access law.
Pharmaceutical giant AbbVie has sued Hawaii over its 340B contract pharmacy access law just three days after the governor signed [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two Drugmakers Appeal Federal District Judge’s 340B Rebate Ruling in Favor of HHS

Two drugmakers are appealing a Washington, D.C. federal district judge's ruling against unilateral 340B rebate models.
Novartis and Bristol Myers Squibb (BMS) are both asking a federal appeals court to overturn a lower court’s ruling that [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: Health Center Group Motion Denied in 5th Circuit; Drug Industry Makes Motion in Federal Court in South Dakota 

Key briefs were filed in litigation on contract pharmacy access laws in Louisiana and South Dakota.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug Industry Files New Lawsuits to Block 340B Contract Pharmacy Access Laws in Tennessee, Utah

AstraZeneca sued to block Utah's 340B contract pharmacy access law one day after PhRMA challenged Tennessee's similar statute.
AstraZeneca and the brand-name drug industry’s leading trade group have filed federal lawsuits challenging newly enacted 340B contract pharmacy access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Amid Federal Court Setbacks, Drugmakers Turn to State Courts to Try to Block 340B Contract Pharmacy Access Laws

The Arkansas Circuit Court of Pulaski County is one of two state courts with drug industry litigation challenging 340B contract pharmacy access laws.
Following a string of losses in federal courts, some drugmakers are now turning to state-level courts in an effort to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: Key Briefs in 8th Circuit, Utah, South Dakota; Motion Filed in 5th Circuit

Key briefs and motions were filed recently in the 8th Circuit and 5th Circuit Appeals Courts, as well as federal district courts in Utah and South Dakota.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Providers Applaud Federal Judge’s 340B Rebate Ruling as Drugmakers Mull Next Steps

340B stakeholders are reacting to U.S District Judge Dabney Friedrich's May 15 ruling on a series of controversial drugmaker 340B rebate lawsuits.
A federal judge’s decision to uphold the government’s authority to pre-approve drugmaker 340B rebate models has drawn praise from providers, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live